Partner, European Patent Attorney
Rebecca handles life sciences patent work in the pharmaceutical and biotechnology sectors.
She has particular expertise in:
Rebecca is recognised in The Legal 500 (2016) as ‘highly active on the life sciences side‘.
She has extensive experience prosecuting applications before the EPO. She also has a strong track record at opposition, including both defending clients’ patents and securing revocation or significant narrowing of those of competitors.
Her clients include large and small biotech companies and technology transfer institutions.
Rebecca spent time as an intern in a large law firm in Washington DC and is a regular visitor to the US.
Rebecca has a degree in biological sciences from the University of Oxford.
Rebecca joined Mewburn Ellis in 2000, qualifying as both a Chartered Patent Attorney and a European Patent Attorney in 2004. She joined the partnership in 2008.